It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The aromatic amino acid L-tryptophan (Trp) is essentially metabolized along the host and microbial pathways. While much is known about the role played by downstream metabolites of each pathways in intestinal homeostasis, their role in lung immune homeostasis is underappreciated. Here we have examined the role played by the Trp hydroxylase/5-hydroxytryptamine (5-HT) pathway in calibrating host and microbial Trp metabolism during Aspergillus fumigatus pneumonia. We found that 5-HT produced by mast cells essentially contributed to pathogen clearance and immune homeostasis in infection by promoting the host protective indoleamine-2,3-dioxygenase 1/kynurenine pathway and limiting the microbial activation of the indole/aryl hydrocarbon receptor pathway. This occurred via regulation of lung and intestinal microbiota and signaling pathways. 5-HT was deficient in the sputa of patients with Cystic fibrosis, while 5-HT supplementation restored the dysregulated Trp partitioning in murine disease. These findings suggest that 5-HT, by bridging host-microbiota Trp partitioning, may have clinical effects beyond its mood regulatory function in respiratory pathologies with an inflammatory component.
Serotonin regulates mood as well as intestinal homeostasis, but its role in lung immune homeostasis is less clear. Here, Renga et al. show that serotonin regulates immune and microbial metabolic functions in respiratory pneumonia, beyond its mood regulatory function, by modulating tryptophan metabolism in the cystic fibrosis lung.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 University of Perugia, Department of Medicine and Surgery, Perugia, Italy (GRID:grid.9027.c) (ISNI:0000 0004 1757 3630)
2 Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche “Togo Rosati,”, Perugia, Italy (GRID:grid.419581.0) (ISNI:0000 0004 1769 6315)
3 CF Centre, Medical University Innsbruck, Innsbruck, Austria (GRID:grid.5361.1) (ISNI:0000 0000 8853 2677)
4 Innsbruck Medical University, Division of Hygiene and Medical Microbiology, Innsbruck, Austria (GRID:grid.5361.1) (ISNI:0000 0000 8853 2677)
5 University of Camerino, School of Biosciences and Veterinary Medicine, Camerino, Italy (GRID:grid.5602.1) (ISNI:0000 0000 9745 6549)
6 University of California, Department of Environmental Toxicology, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684)
7 University San Raffaele and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele, Rome, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884)
8 University of Perugia, Department of Medicine and Surgery, Perugia, Italy (GRID:grid.9027.c) (ISNI:0000 0004 1757 3630); University San Raffaele and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele, Rome, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884)